UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027161
Receipt number R000030924
Scientific Title TOPICal Steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy : a phase III, randomized, double-blinded trial
Date of disclosure of the study information 2017/05/01
Last modified on 2017/11/13 16:25:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

TOPICal Steroid versus placebo for the prevention of radiation dermatitis
in head and neck cancer patients receiving chemoradiotherapy
: a phase III, randomized, double-blinded trial

Acronym

TOPICS study(J-SUPPORT 1602)

Scientific Title

TOPICal Steroid versus placebo for the prevention of radiation dermatitis
in head and neck cancer patients receiving chemoradiotherapy
: a phase III, randomized, double-blinded trial

Scientific Title:Acronym

TOPICS study(J-SUPPORT 1602)

Region

Japan


Condition

Condition

Locally Advanced Squamous Cell Carcinoma of the Head and Heck

Classification by specialty

Medicine in general Oto-rhino-laryngology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the prophylactic effect of topical steroid for radiation dermatitis in SCCHN patients receiving hcemoradiotherapy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase III


Assessment

Primary outcomes

The frequency of radiation dermatitis grade2

Key secondary outcomes

The frequency of radiation dermatitis grade2
Treatment comliance
The frequency of local infection
The duration of grade2/3/4 radiation dermatitis
the rate of radiation dermatitis grade 2 at 2weeks after the end of radiotherapy
Toxicties(including PRO-CTCAE)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Basic nursing care with Topical steroid
Start:develop to Grade 1 radiation dermatitis or recieced 30Gy of RT
Finish:Improved to Grade 1 radiation dermatitis or 8 weeks after start of this treatmen

Interventions/Control_2

Basic nursing care with Topical placebo
Start:develop to Grade 1 radiation dermatitis or recieced 30Gy of RT
Finish:Improved to Grade 1 radiation dermatitis or 8 weeks after start of this treatment

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

*PS 0-1
*Have a plan to receive CRT,CDDP/RT
*Have a plan to receive >66Gy radiotherapy
*Have a plan to receive >200mg/m2 CDDP during RT
*No diseases related with dermatitis
*Written in informed consent

Key exclusion criteria

Received steroid therapy before this treatment
Have an infection
Have allergies to Vaseline or topical steroid
Have severe complications

Target sample size

220


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Sadamoto Zenda

Organization

National Cancer Center Hospital East

Division name

Department of Radiation Oncology

Zip code


Address

6-5-1 Kashiwanoha Kashiwa Chiba, Japan

TEL

04-7133-1111

Email

szenda@east.ncc.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Sadamoto Zenda

Organization

National Cancer Center Hospital East

Division name

Department of Radiation Oncology

Zip code


Address

6-5-1 Kashiwanoha Kashiwa Chiba, Japan

TEL

04-7133-1111

Homepage URL


Email

szenda@east.ncc.go.jp


Sponsor or person

Institute

Department of Radiation Oncology, National Cancer Center Hospital East

Institute

Department

Personal name



Funding Source

Organization

The National Cancer Center Research and Development Fund ( 27-A-3)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)

Project Mirai Cancer Research Grants


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 04 Month 27 Day

Date of IRB


Anticipated trial start date

2017 Year 05 Month 07 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 04 Month 27 Day

Last modified on

2017 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030924


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name